CAJ | 학술논문

目的：为观察尿激酶对结核性纤维化性胸腔积液的治疗作用。方法：在应用2SHRZ/4—6HR方案规则治疗下，对32例胸液包裹、纤维化的结核性胸腔积液病人胸腔内注入10万U尿激酶，另外32例胸腔内注入氢化考的松100mg作对照。结果：治疗组32例中，28例(87.50%)达到显效，4例(12.50%)好转，有效率100%。结论：胸膜腔内注入尿激酶可消除胸腔积液纤维化，增加引流量，改善肺功能，疗效显著。
목적：위관찰뇨격매대결핵성섬유화성흉강적액적치료작용。방법：재응용2SHRZ/4—6HR방안규칙치료하，대32례흉액포과、섬유화적결핵성흉강적액병인흉강내주입10만U뇨격매，령외32례흉강내주입경화고적송100mg작대조。결과：치료조32례중，28례(87.50%)체도현효，4례(12.50%)호전，유효솔100%。결론：흉막강내주입뇨격매가소제흉강적액섬유화，증가인류량，개선폐공능，료효현저。
Objective　To observe the effects of intrapleural injection of urokinase for patients with encapsulated tuberculous pleural effusion.Method　Regular antituberculosis treatment was given to all patients observed.Urokinase was injected one hundred thousands/day respectively into the pleural cavity of 32 patients with encapsulation tuberculous.While hydrocortisone of 100mg was injected into the pleural cavity of 32 patients of the control group.Results　87.50%(28/32)of the 32 cases of the study group achieved complete improvement 12.50%(4/32)of the studied cases achieved partial improvement.The operative rate of urokinase group was 100%.Conclusion　For patients with encapsulated tuberculous pleural effusion,regular a ntituberculosis treatment plus urokinase injection into the pleural cavity can increase the drain-age,decrease pleural thichening and improve pulmonary function of the patients.